Blood Culture Test Market Will Reach Nearly USD 9.72 Billion, Expanding at a CAGR of 9.6% during the Forecast Period of 2030 | Reports and Data

The global blood culture test market size is expected to reach USD 9.72 Billion in 2030 and register a revenue CAGR of 9.6% over the forecast period, according to latest report by Reports and Data.

The global blood culture test market size is expected to reach USD 9.72 Billion in 2030 and register a revenue CAGR of 9.6% over the forecast period, according to latest report by Reports and Data. Increasing incidence of bloodstream infections, sepsis, and infectious diseases is expected to drive market revenue growth during the forecast period. Growing demand for blood culture tests in developing countries is also expected to boost revenue growth of the market.

Access Free Sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1461

Bloodstream Infections (BSIs) are infectious disorders caused by active bacterial or fungal germs in the bloodstream, which cause an inflammatory response shown by changes in clinical, laboratory, and hemodynamic parameters. Infections of the bloodstream are one of the major causes of deaths worldwide, and such illnesses extend time spent in hospitals, along with increasing the cost of treatment. Demand for advanced blood culture techniques that aid in early diagnosis of infections is expected to increase due increasing prevalence of BSIs, which in turn, is expected to boost revenue growth of the global blood culture test market during the forecast period.

However, increasing costs of automated equipment and lack of laboratory professionals are expected to hamper revenue growth of the market during the forecast period. Automated blood culture devices are expensive, as they have complex features and functions. For instance, automated equipment for Polymerase Chain Reaction (PCR) test costs between USD 15,000 and USD 20,000. Academic research laboratories usually cannot afford such high-priced systems due to financial constraints, and moreover, the overall cost of ownership of these instruments increases due to maintenance charges and a number of additional factors. This is a key barrier to the adoption of automated blood culture instruments, particularly among small-scale end users. There is increasing need for medical laboratory experts, but the number of new students graduating from clinical laboratory programs is dropping due to program closures. This is creating a major challenge in the growth of blood culture test market.

Some Key Highlights in the Report

    • Conventional segment is expected to account for largest revenue share in the global blood culture test market over the forecast period, owing to rising use of convetional or traditional blood culture methods in independent clinical laboratories, hospitals, and pathology labs.
    • Consumable segment is expected to register a steady revenue growth rate over the forecast period, due to increase in demand for blood culture media, assays, kits, and reagents.
    • Molecular technology segment is expected to register a rapid revenue growth rate over the forecast period, due to increase in demand for improved equipment in hospitals and laboratories for infectious disease diagnostics.
    • The blood culture test market in North America is expected to account for largest revenue share in the global market over the forecast period. Rising awareness about new diagnostic methods and presence of well-established healthcare facilities in the region are expected to drive North America market revenue growth.

Competitive Landscape:

The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.

Top Companies Profiled in the Report:

Becton, Dickinson and Company, Thermo Fisher Scientific Corporation, Luminex Corporation, Danaher Corporation, Bruker Corporation, Ibis Biosciences, Inc., Hoffmann-La Roche AG, Meditech Technologies India Pvt. Ltd., Magnolia Medical Technologies, and Carl Zeiss AG.

To know more about the report, visit @ https://www.reportsanddata.com/report-detail/blood-culture-tests-market

Blood Culture Test Market Segmentation:

Method Outlook (Revenue, USD Billion; 2019-2030)

  • Conventional/Manual Method
  • Automated Method

Product Outlook (Revenue, USD Billion; 2019-2030)

  • Instruments
    • Automated Blood Culture System
    • Supporting Laboratory Equipment
  • Incubators
  • Microscopes
  • Colony Counters
  • Gram Stainers
    • Consumable
      • Blood Culture Accessories
      • Assay Kits and Reagents
      • Blood Culture Media
    • Aerobic Blood Culture Media
    • Pediatric Aerobic Blood Culture Media
    • Fungi/Yeast Blood Culture Media
      • Software and Service

Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Ask for Customized Research Report @ https://www.reportsanddata.com/request-customization-form/1461

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

Explore Latest Trending Research Reports By Reports and Data:

Microcatheters Market By Product Type (Delivery, Aspiration, Diagnostic, Steerable, and Others), By Product Design (Single Lumen and Dual Lumen), By Application (Cardiology, Neurology, Peripheral Vascular, Oncology, Urology, Otolaryngology, and Others), By End-Use (Hospital, Surgical Centers, Specialty Clinics, and Ambulatory Surgical Centers), and By Region Forecast to 2028

Pharmaceutical Grade Sodium Chloride Market , By Product Type (API-NaCl, HD-NaCl), By Application (Channeling Agents/Osmotic Agent, Mechanical Cleansing Solutions, Peritoneal Dialysis, Hemofiltration Solutions, Injections, Hemodialysis, Oral Rehydration Salts, Others), and By Region Forecast to 2028

Bone Allografts and Xenografts Market By Product Type (Allografts, Xenografts, and Others), By Application (Spinal Fusion, Bone Trauma, and Others), and By Region Forecast to 2028

Enteric Empty Capsules Market Size, Share & Growth By Type (Gelatin Type, HPMC Type, Vegetable Other), By Application (Antacid and Antiflatulent Preparations, Antibiotic and Antibacterial Drugs), By End Use (Pharmaceutical, Health Supplements, Others), And Region Forecast To 2028

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs